Future shows great potential for neurological language assessments in clinical trials.
Jessica Robin
Advertisement
Director of Clinical Research, Winterlight Labs
Articles by Jessica Robin
Advertisement
Latest Updated Articles
How Speech-Based Digital Biomarkers are Redefining the Measurement of Disease Progression in Neurodegenerative Dementia TrialsPublished: March 15th 2022 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Praxis Reports Positive Phase III Results for Ulixacaltamide in Essential Tremor
2
Setting the Limits of Autonomy with Autonomous Agents for Clinical Research
3
Adaptive Trial Design as a Pathway to Faster Development
4
Eli Lilly’s Orforglipron Shows Superior Efficacy Across Multiple Phase III Trials in Type 2 Diabetes
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
